BPWM
ONCY

Badgley Phelps Wealth Managers’s Oncolytics Biotech ONCY Stock Holding History

Badgley Phelps Wealth Managers’s Portfolio ONCY Stock Details ONCY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$38K Buy
+40,000
New +$37.1K ﹤0.01% 332
2026
Q1 		– Sell
-40,000
Closed -$35K – 335
2025
Q4 		$35K Hold
40,000
– – ﹤0.01% 326
2025
Q3 		$56K Hold
40,000
– – ﹤0.01% 294
2025
Q2 		$30.9K Hold
40,000
– – ﹤0.01% 295
2025
Q1 		$22K Buy
+40,000
New +$29.3K ﹤0.01% 299

Other funds holding ONCY

IAIM
International Assets Investment Management Orlando, Florida $1.67B AUM 28.26% 1-Year Est. Return
EFG
Everhart Financial Group Dublin, Ohio $1.56B AUM 34.29% 1-Year Est. Return
PI
PFG Investments Woodbury, New York $2.58B AUM 36.93% 1-Year Est. Return
DA
Doliver Advisors Houston, Texas $442M AUM 34.09% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
PAS
Professional Advisory Services Vero Beach, Florida $836M AUM 25.79% 1-Year Est. Return
Truist Financial
Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
CIA
Concurrent Investment Advisors Tampa, Florida $11.8B AUM 31.86% 1-Year Est. Return

Badgley Phelps Wealth Managers's ONCY Position: Q2 2026 in Review

Badgley Phelps Wealth Managers opened a new position in Oncolytics Biotech (ONCY) in Q2 2026: 40,000 shares worth $38K. The stake represents ﹤0.01% of the portfolio and ranks #332 among its holdings. This is a return to the name: Badgley Phelps Wealth Managers previously reported a position in ONCY as recently as Q4 2025.

Badgley Phelps Wealth Managers first reported a position in ONCY in Q1 2025 and has held it in 5 quarters since. The position peaked at $56K in Q3 2025. 24 funds tracked by Wall St. Rank hold ONCY as of Q2 2026.

  • Badgley Phelps Wealth Managers held 40,000 shares of Oncolytics Biotech worth $38K as of Q2 2026.
  • Oncolytics Biotech was a new Badgley Phelps Wealth Managers position in Q2 2026.
  • Oncolytics Biotech made up ﹤0.01% of Badgley Phelps Wealth Managers's portfolio in Q2 2026, its #332 holding.
  • Badgley Phelps Wealth Managers first reported a position in Oncolytics Biotech in Q1 2025 and has held it in 5 quarters since.
  • Badgley Phelps Wealth Managers's Oncolytics Biotech position peaked at $56K in Q3 2025.
  • 24 funds tracked by Wall St. Rank held Oncolytics Biotech as of Q2 2026.

Based on Badgley Phelps Wealth Managers's 13F filing for Q2 2026, filed 31 Jul 2026.